Top

AJ11--(UMICH) Dr. Thomas Sisson/Osterholzer Notice Of Intent to Sole Source

Active

36C25022C0086Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Department of Veterans Affairs, VA Ann Arbor Medical Center, intends to engage the University of Michigan on a sole source basis for the consulting services of Dr. Thomas Sisson, a recognized expert in lung epithelial cell biology and pulmonary fibrosis. Dr. Sisson will serve as a Co-Investigator alongside Principal Investigator Dr. John Osterholzer on a VA-funded study focused on advancing non-invasive diagnostics and treatments for deployment-related chronic lung disease in Gulf War veterans. His contributions will involve reviewing data, assisting in manuscript preparation, ensuring proper statistical analysis, and publishing results, all performed from his office at the University of Michigan. Dr. Sisson and Dr. Osterholzer have a well-established collaborative history, including multiple co-publications and ongoing joint research efforts funded by DOD and NIH grants. The contract covers a base period from May 1, 2022, through April 30, 2023, with two option years extending through July 31, 2024. NAICS code 541715 and PSC code AJ11 apply to this procurement, which is conducted under FAR 13.106-1(b) and does not involve competitive solicitation. The notice emphasizes that it is not a solicitation but a notice of intent for sole source acquisition, with responses required by April 22, 2022, demonstrating that competition would benefit the government. The contracting officer for this effort is Kevin Adkins, with email correspondence directed to him for any inquiries or submissions.

General Info

VA contracts University of Michigan for sole source consulting on Gulf War lung disease study, 2022-2024.

Agency

Department Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Set-Aside

NONE

Documents

Notice of Intent to Sole Source - Dr. Thomas Sisson/Osterholzer

2 pages · justification-and-authorization

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PostedApr 11

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Contacts1 person available

OfficeDAYTON, OH, 45428, USA

Organization / AgencyDepartment Of Veterans Affairs → 250-NETWORK Contract Office 10 (36C250)

Office AddressDAYTON, OH, 45428, USA

Contacts

Kevin AdkinsContracting Officer

contact@example.gov

Full Description

The Department of Veterans Affairs, VA Ann Arbor Medical Center VISN 10, 2215 Fuller Road, Ann Arbor MI 48105, in accordance with FAR 13.106-1(b), intends to request quotation on a sole source basis with University of Michigan for the provision of the services of Dr. Thomas Sisson. NAICS 541715 and PSC code AJ11 apply. Dr. Thomas Sisson will serve as a Co-Investigator on the VA-funded study entitled Advancing Non-Invasive Diagnostics and Treatments of Deployment-Related Chronic Lung Disease in Gulf War Veterans with John Osterholzer, MD as the Principal Investigator requires the services of a consultant to provide technical assistance in fibrosis biology. Dr. Sisson will perform his portion of the work from his office at the University of Michigan. There he will review recent data and assess with manuscript preparation. Furthermore, he will ensure that there are proper statistical comparisons of data and publish the data. Dr. Sisson is a Professor in Internal Medicine at the University of Michigan. He is a recognized expert in the field of lung epithelial cell biology with extensive experience investigating cellular and molecular mechanisms lung epithelial injury and pulmonary fibrosis. He developed a novel model of repetitive gene-targeted injury to type II alveolar epithelial cells and assisted Dr. Osterholzer in the generation of preliminary data demonstrating a protective effect of CD36 deficiency in response to apoptotic cells and oxidized phospholipid. He and Dr. Osterholzer have an established and productive collaborative relationship as evidenced by 3 co-publications, 2 manuscripts in preparation, and reciprocal Co-Investigator status on recent DOD and NIH grants. Periods of performance are estimated as follows: Base Period of Performance: 05/01/2022 04/30/2023 Option Year 1: 05/01/2023 04/30/2024 Option Year 2: 05/01/2024-07/31/2024 This notice of intent is not a request for competitive proposals. It is not a solicitation or request for offers. No solicitation package is available. A determination not to compete is solely within the discretion of the Government. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Responses must be received no later than 12:00 pm CDT on Friday April 22, 2022. No telephone inquiries will be accepted. All responses must be sent by email to contact@example.gov